Headlands Technologies’s ARK Genomic Revolution ETF ARKG Stock Holding History

Headlands Technologies’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$426K	Buy	+10,128	New	+$323K	0.05%	452
2025 Q2	–	Sell	-2,149	Closed	-$44.6K	–	1170
2025 Q1	$44.6K	Buy	+2,149	New	+$54K	0.01%	735
2024 Q3	–	Sell	-21,163	Closed	-$497K	–	1172
2024 Q2	$497K	Buy	21,163 +20,809	+5,878%	+$525K	0.05%	278
2024 Q1	$10.2K	Buy	+354	New	+$10.6K	﹤0.01%	1026
2023 Q2	–	Sell	-3,653	Closed	-$110K	–	780
2023 Q1	$110K	Buy	+3,653	New	+$113K	0.07%	174

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Headlands Technologies's ARKG Position: Q2 2026 in Review

Headlands Technologies opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 10,128 shares worth $426K. The stake represents 0.05% of the portfolio and ranks #452 among its holdings. This is a return to the name: Headlands Technologies previously reported a position in ARKG as recently as Q1 2025.

Headlands Technologies first reported a position in ARKG in Q1 2023 and has held it in 5 quarters since. The position peaked at $497K in Q2 2024. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Headlands Technologies held 10,128 shares of ARK Genomic Revolution ETF worth $426K as of Q2 2026.
ARK Genomic Revolution ETF was a new Headlands Technologies position in Q2 2026.
ARK Genomic Revolution ETF made up 0.05% of Headlands Technologies's portfolio in Q2 2026, its #452 holding.
Headlands Technologies first reported a position in ARK Genomic Revolution ETF in Q1 2023 and has held it in 5 quarters since.
Headlands Technologies's ARK Genomic Revolution ETF position peaked at $497K in Q2 2024.
272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.